MMP9 and stroke disorder: The TLR4/MMP9-mediated reduction of astrocyte reactivity after ECS activation via CB2R is of special interest for stroke, as it has been suggested elsewhere that attenuation of the inflammatory process could be neuroprotective after tMCAO in rats (Piao et al., 2003).